132 related articles for article (PubMed ID: 21125389)
1. Engineering unusual amino acids into peptides using lantibiotic synthetase.
Nagao J; Shioya K; Harada Y; Okuda K; Zendo T; Nakayama J; Sonomoto K
Methods Mol Biol; 2011; 705():225-36. PubMed ID: 21125389
[TBL] [Abstract][Full Text] [Related]
2. Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli.
Nagao J; Harada Y; Shioya K; Aso Y; Zendo T; Nakayama J; Sonomoto K
Biochem Biophys Res Commun; 2005 Oct; 336(2):507-13. PubMed ID: 16143300
[TBL] [Abstract][Full Text] [Related]
3. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
4. Characterization of modification enzyme NukM and engineering of a novel thioether bridge in lantibiotic nukacin ISK-1.
Shioya K; Harada Y; Nagao J; Nakayama J; Sonomoto K
Appl Microbiol Biotechnol; 2010 Apr; 86(3):891-9. PubMed ID: 19915831
[TBL] [Abstract][Full Text] [Related]
5. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
6. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
[TBL] [Abstract][Full Text] [Related]
7. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
[TBL] [Abstract][Full Text] [Related]
8. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
9. The genetics of lantibiotic biosynthesis.
Jack R; Bierbaum G; Heidrich C; Sahl HG
Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
[TBL] [Abstract][Full Text] [Related]
10. Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides.
Moll GN; Kuipers A; Rink R
Antonie Van Leeuwenhoek; 2010 May; 97(4):319-33. PubMed ID: 20140513
[TBL] [Abstract][Full Text] [Related]
11. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.
Rink R; Kuipers A; de Boef E; Leenhouts KJ; Driessen AJ; Moll GN; Kuipers OP
Biochemistry; 2005 Jun; 44(24):8873-82. PubMed ID: 15952794
[TBL] [Abstract][Full Text] [Related]
12. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
[TBL] [Abstract][Full Text] [Related]
13. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
14. Localization and interaction of the biosynthetic proteins for the lantibiotic, Nukacin ISK-1.
Nagao J; Aso Y; Sashihara T; Shioya K; Adachi A; Nakayama J; Sonomoto K
Biosci Biotechnol Biochem; 2005 Jul; 69(7):1341-7. PubMed ID: 16041140
[TBL] [Abstract][Full Text] [Related]
15. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
17. Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin.
Kluskens LD; Kuipers A; Rink R; de Boef E; Fekken S; Driessen AJ; Kuipers OP; Moll GN
Biochemistry; 2005 Sep; 44(38):12827-34. PubMed ID: 16171398
[TBL] [Abstract][Full Text] [Related]
18. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
[TBL] [Abstract][Full Text] [Related]
19. Theoretical analysis of amino acid-producing Escherichia coli using a stoichiometric model and multivariate linear regression.
Van Dien SJ; Iwatani S; Usuda Y; Matsui K
J Biosci Bioeng; 2006 Jul; 102(1):34-40. PubMed ID: 16952834
[TBL] [Abstract][Full Text] [Related]
20. Methodologies and strategies for the bioengineering of lantibiotics.
Nagao J; Nishie M; Sonomot K
Curr Pharm Biotechnol; 2011 Aug; 12(8):1221-30. PubMed ID: 21470152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
